Correlation Between CellaVision and Genovis AB

Can any of the company-specific risk be diversified away by investing in both CellaVision and Genovis AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CellaVision and Genovis AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CellaVision AB and Genovis AB, you can compare the effects of market volatilities on CellaVision and Genovis AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CellaVision with a short position of Genovis AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of CellaVision and Genovis AB.

Diversification Opportunities for CellaVision and Genovis AB

-0.55

Correlation Coefficient

CellaVision  Genovis AB

Excellent diversification

The 3 months correlation between CellaVision and Genovis is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding CellaVision AB and Genovis AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genovis AB and CellaVision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CellaVision AB are associated (or correlated) with Genovis AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genovis AB has no effect on the direction of CellaVision i.e., CellaVision and Genovis AB go up and down completely randomly.

Pair Corralation between CellaVision and Genovis AB

Assuming the 90 days trading horizon CellaVision AB is expected to under-perform the Genovis AB. But the stock apears to be less risky and, when comparing its historical volatility, CellaVision AB is 1.67 times less risky than Genovis AB. The stock trades about -0.11 of its potential returns per unit of risk. The Genovis AB is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2,510  in Genovis AB on December 1, 2024 and sell it today you would earn a total of  230.00  from holding Genovis AB or generate 9.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CellaVision AB  vs.  Genovis AB

CellaVision AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Genovis AB

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Genovis AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Genovis AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CellaVision and Genovis AB

The main advantage of trading using opposite CellaVision and Genovis AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CellaVision position performs unexpectedly, Genovis AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovis AB will offset losses from the drop in Genovis AB's long position.

The idea behind CellaVision AB and Genovis AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.